Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Propanc Biopharma Inc (PPCB) Stock-Based Compensation data is not available for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-4.02M |
|
-- |
|
-- |
|
$3.65M |
|
$-3.65M |
|
$0.56M |
|
$-3.09M |
|
$-3.09M |
|
$-3.09M |
|
$-3.09M |
|
$-3.09M |
|
$-3.09M |
|
$-3.65M |
|
$-3.65M |
|
13.36M |
|
13.36M |
|
$-0.30 |
|
$-0.30 |
|
| Balance Sheet Financials | |
$7.71M |
|
$0.00M |
|
$7.40M |
|
$15.11M |
|
$3.62M |
|
-- |
|
$1.04M |
|
$4.66M |
|
$10.45M |
|
$10.45M |
|
$10.45M |
|
13.45M |
|
| Cash Flow Statement Financials | |
$-2.94M |
|
$-0.00M |
|
$3.49M |
|
$0.01M |
|
$0.56M |
|
$0.55M |
|
|
Stock-Based Compensation |
-- |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.13 |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.94M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-29.58% |
|
-29.58% |
|
-20.46% |
|
-29.58% |
|
$0.78 |
|
$-0.22 |
|
$-0.22 |
|